Clinical Trial Update: Study of the Efficacy and Safety of Kalinox® 170 Bar for the Performance of Care Procedures in Children With Burns [Phase 3]

View source ↗

Summary

Phase 3 clinical trial of Kalinox 170 Bar for performing care procedures in children with burns has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Burns

Drugs mentioned

• Kalinox (nitrous oxide/oxygen inhalation mixture)

Snippet

Sponsor: Air Liquide Santé International | Conditions: Burns | Phase 3 | Status: WITHDRAWN